Sens. Orrin Hatch and Charles Grassley want to know whether not-for-profit hospitals are abusing their tax-exempt status and what the IRS is doing about any potential violations.
The two largest healthcare payers plan to work together to curb fraud and abuse within their networks in a rare collaboration.
Sen. Ron Wyden (D-Ore.) believes that CMS Administrator Seema Verma may have broken her conflict of interest agreements by weighing in on several Medicaid waivers. Public records indicate she may not have done anything wrong.
A slew of cities and counties in Indiana have joined the growing ranks of municipalities and states that have sued the major drug distributors for allegedly overlooking suspicious opioid prescriptions and fueling the abuse epidemic.
Gov. C.L. "Butch" Otter signed an executive order directing the state Department of Insurance to create guidelines for health insurance carriers to offer lower-priced coverage plans.
21st Century Oncology, a cancer-care provider, has agreed to pay HHS $2.3 million to settle allegations that it didn't implement proper protocols to protect patient information from hackers.
The Food and Drug Administration issued a new proposal for regulating homeopathic medicines that have long been on the fringe of mainstream medicine. The agency plans to target products that pose the biggest safety risks, including those marketed for children or for serious diseases.
Washington's insurance commissioner fined Centene subsidiary Coordinated Care $1.5 million and briefly banned it from selling individual plans because of its inadequate provider network.
HHS' Office of Inspector General said the CMS must work on ways to provide technical assistance to clinicians for MACRA participation and create a more robust integrity program.
DaVita Rx, the pharmacy services unit of kidney dialysis giant DaVita, will pay $63.7 million to settle allegations that it presented false claims to the federal government for prescription medications, and that it provided unlawful financial incentives to Medicare beneficiaries.
The Salt Lake City-based health system will pay the federal government $1 million to settle allegations that a former medical assistant illegally diverted thousands of painkillers and other pills for personal use by herself and family members.
The FDA's new guidance aims to make it easier for generic firms to plan how they can copy complex drugs like epinephrine auto-injectors, which should ultimately lower pharmaceutical prices.